Xiaoming Zha

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Epithelial Mesenchymal Transition

Early Breast Cancer

Sentinel Lymph Node

Top Venues

Clinical and translational medicine

Nanomedicine (London, England)

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyu Wan, Wenjie Shi, Lingjun Ma, Lexin Wang, Ran Zheng, Jinzhi He, Ye Wang, Xuan Li, Xiaoming Zha, Jue Wang, Lu Xu
A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer. Clinical and translational medicine 14 (5) (2024)
Xuan Li, Lexin Wang, Yuanyuan Wang, Lingjun Ma, Ran Zheng, Jingjing Ding, Yichun Gong, Hao Yao, Jue Wang, Xiaoming Zha
Omission of sentinel lymph node biopsy in patients with clinically axillary lymph node-negative early breast cancer (OMSLNB): protocol for a prospective, non-inferiority, single-arm, phase II clinical trial in China. BMJ open 14 (9) (2024)
Xinyu Wan, Wenjie Shi, Lingjun Ma, Lexin Wang, Ran Zheng, Jinzhi He, Ye Wang, Xuan Li, Xiaoming Zha, Jue Wang, Lu Xu
A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer. Clinical and translational medicine 14 (5) (2024)
Xinyu Wan, Wenjie Shi, Lingjun Ma, Lexin Wang, Ran Zheng, Jinzhi He, Ye Wang, Xuan Li, Xiaoming Zha, Jue Wang, Lu Xu
A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer. Clinical and translational medicine 14 (5) (2024)
Xinyu Wan, Wenjie Shi, Lingjun Ma, Lexin Wang, Ran Zheng, Jinzhi He, Ye Wang, Xuan Li, Xiaoming Zha, Jue Wang, Lu Xu
A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer. Clinical and translational medicine 14 (5) (2024)
Rui Chen, Shuo Li, Yan Li, Qiannan Zhu, Xiaoqing Shi, Lu Xu, Yinggang Xu, Weiwei Zhang, Xiaofeng Huang, Jue Wang, Xiaoming Zha
Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China. Journal of cancer research and clinical oncology 147 (12) (2021)
Yan Li, Xiang Chen, Qiannan Zhu, Rui Chen, Lu Xu, Shuo Li, Xiaoqing Shi, Haiping Xu, Yinggang Xu, Weiwei Zhang, Xiaofeng Huang, Xiaoming Zha, Jue Wang
Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer. Nanomedicine (London, England) 16 (5) (2021)
Haiping Xu, Rui Chen, Chaojun Jiang, Sainan You, Qiannan Zhu, Yan Li, Shuo Li, Xiaoming Zha, Jue Wang
Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer. The journal of vascular access 21 (5) (2019)